封面
市場調查報告書
商品編碼
2008020

生物製藥一次性產品市場:依產品類型、最終用戶和地區分類

Single Use Products in Biopharmaceuticals Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年一次性生物製藥產品的市場規模估計為217億美元,預計到2033年將達到344億美元。預計從2026年到2033年,其複合年成長率將達到11.7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 217億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 11.70% 2033年市場規模預測: 344億美元

生物製藥生產過程中使用的一次性產品是指使用一次後即被丟棄,不能重複用於生產的產品。這些一次性產品通常使用塑膠、聚乙烯和紙張等材料製造過濾裝置。一次性產品能夠降低昂貴設備的成本和細胞培養過程中的污染風險,並縮短生產時間,減少測試、驗證和文件編制工作。在藥物研發、疫苗生產和其他醫療創新推動下,全球生物製藥市場正快速成長,預計這將進一步推動生物製藥生產過程中所需一次性產品的市場需求。

市場動態

市場參與者正透過與其他公司合作,擴大其在一次性生物製藥產品市場的佔有率,預計這將進一步推動全球一次性生物製藥產品市場在預測期內的成長。例如,2021年9月9日,治療藥物研發和生產技術及服務提供者Cytiva決定擴大其在中國的一次性生物製藥產品產能。透過與醫療技術供應商Wego Pharmaceutical Co.的合作,Cytiva在亞太地區的一次性產品供給能力將增加兩倍。

醫藥市場研發和投資活動的不斷增加正在推動對一次性產品的需求,預計這將促進全球一次性生物製藥市場在預測期內的成長。例如,根據印度品牌股權基金會(IBEF)於2021年12月7日發布的數據,印度政府正在為製藥業提供政策支援。印度財政部於2021年6月宣布,將在未來五年內提供265.783億美元擴大研發活動。

本次調查的主要特點。

  • 本報告對全球一次性生物製藥市場進行了詳細分析,給出了預測期(2026-2033 年)的市場規模(以十億美元計)和複合年成長率(CAGR%),其中 2025 年為基準年。
  • 本報告指出了各個細分市場的潛在商機,並說明了該市場中具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數分析了全球一次性生物製藥市場的主要企業:公司概況、財務績效、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
  • 透過利用本報告中提出的見解,企業行銷負責人和經營團隊可以就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 本報告面向該產業的各類相關人員,包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
  • 透過各種策略矩陣分析全球生物製藥一次性產品市場,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場概覽

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 法規環境
  • PEST分析
  • 近期產品發布及核准
  • 流行病學
  • 併購

第4章 全球生物製藥一次性產品市場:依產品類型分類,2026-2033年

  • 工作設備
  • 裝置

第5章 全球生物製藥一次性產品市場:依最終用戶分類,2026-2033年

  • 製藥公司
  • 生技公司
  • 研究機構

第6章 全球生物製藥一次性產品市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第7章 競爭情勢

  • 公司簡介
    • Aber instruments
    • Adolf Kuhner AG
    • Thermo Fisher Scientific
    • Bio-equip
    • Pall corp
    • C-Cit Sensors AG
    • Corning Life Sciences
    • Eppendorf
    • GE Healthcare
    • Gemu GmbH
    • Merck
    • Avantor
    • Meissner
    • New Horizon Biotech
    • PBS-Biotech
    • Xcellerex
    • Single Use Support GmbH.

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4903

Single Use Products In Biopharmaceuticals Market is estimated to be valued at USD 21.7 Bn in 2026 and is expected to reach USD 34.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 21.7 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.70% 2033 Value Projection: USD 34.4 Bn

Single use products used in biopharmaceutical manufacturing process can refer to a product that is used only once and then discard, these single use products cannot be reused for processing purposes. The materials used for manufacturing these single use products are plastic, polyethylene, paper for filtration unit. Single use products reduces the expenses of high cost equipment, risk of contamination in cell culture, reducing the time, testing, validation, and documentation of manufacturing product. As biopharmaceutical market is booming globally for drug development, vaccine production, and other medicinal innovations, this is expected to drive the market of single use products required in biopharmaceutical processing.

Market Dynamics

Market players are expanding their single use products in biopharmaceuticals market with collaborations with other companies, which is further expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on September 9, 2021, Cytiva, a provider of technologies and services used in development and manufacture in therapeutics, decided to expand its manufacturing capacity of single use product in biopharmaceutical in China. In collaboration with Wego Pharmaceutical Co., which is a supplier of healthcare technologies will triple the supply capacity of single use product in Asia Pacific by Cytiva.

The increasing research and development, investment activities in pharmaceutical market increases the requirement of single use products and this is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, According to India Brand Equity Foundation (IBEF) data published on December 7, 2021, in which reports that the Indian government has provided policy assistance to the pharmaceutical business, with the Ministry of Finance of India announcing US$ 26,578.3 million in financing for the next five years to increase research and development operations in June 2021.

Key features of the study

  • This report provides an in-depth analysis of global single use products in biopharmaceutical market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global single use products in biopharmaceutical market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Aber instruments, Adolf Kuhner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor , Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex, and Single Use Support GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global single use products in biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use products in biopharmaceutical market

Market Segmentation

  • By Product Type
    • Work Equipment
    • Flask
    • Containers
    • Syringes
    • Pipettes tips
    • Centrifuge tubes
    • Hand Gloves
    • Face Mask
    • Filters
    • Tubes
    • Others
    • Apparatus
    • Single Use Bioreactor
    • Isolators
    • Membrane Valves
    • Canister
    • Chromatography Systems
    • Filtration Systems
    • Mixing Systems
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies and Research Institutes
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Aber instruments
    • Adolf Kuhner AG
    • Thermo Fisher Scientific
    • Bio-equip
    • Pall corp.
    • C-Cit Sensors AG
    • Corning Life Sciences
    • Eppendorf
    • GE Healthcare
    • Gemu GmbH
    • Merck
    • Avantor
    • Meissner
    • New Horizon Biotech
    • PBS-Biotech
    • Xcellerex
    • Single Use Support GmbH.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. Global Single Use Products in Biopharmaceuticals Market, By Product Type, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Work Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Flask
      • Containers
      • Syringes
      • Pipettes Tips
      • Centrifuge Tubes
      • Hand Gloves
      • Face Mask
      • Filters
      • Tubes
      • Others
  • Apparatus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Single Use Bioreactor
      • Isolators
      • Membrane Valves
      • Canister
      • Chromatography Systems
      • Filtration Systems
      • Mixing Systems
      • Others

5. Global Single Use Products in Biopharmaceuticals Market, By End User, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Single Use Products in Biopharmaceuticals Market, By Region, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Company Profiles
    • Aber instruments
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Adolf Kuhner AG
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Bio-equip
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Pall corp
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • C-Cit Sensors AG
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Corning Life Sciences
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Eppendorf
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • GE Healthcare
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Gemu GmbH
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Merck
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Avantor
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Meissner
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • New Horizon Biotech
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • PBS-Biotech
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Xcellerex
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Single Use Support GmbH.
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact